Skip to content

A systematic review of the function of " Bifidobacterium longum BB536 (B.longum), Bifidobacterium breve B-3 (B.breve)" to the reduction of abdominal fat, and the improvement of high BMI

A systematic review of the function of " Bifidobacterium longum BB536 (B.longum), Bifidobacterium breve B-3 (B.breve) " to the reduction of abdominal fat, and the improvement of high BMI - A systematic review of the function of " Bifidobacterium longum BB536 (B.longum), Bifidobacterium breve B-3 (B.breve) " to the reduction of abdominal fat, and the improvement of high BMI

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000054835
Enrollment
Unknown
Registered
2024-07-02
Start date
2024-07-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults (those who are not suffering from any diseases, excluding those under 18 years old, pregnant women, and lactating women)

Interventions

None listed

Sponsors

FANCL Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: P-Participant: Participant The subjects were healthy volunteers (excluding those under 18, pregnant women, and lactating women, who were not suffering from any diseases). I-Intervention: Intervention (food) characteristics The intervention condition was defined as the intake of foods containing " Bifidobacterium longum BB536 (B.longum), Bifidobacterium breve B-3 (B.breve) ", with unlimited intake quantities, intake period, and follow-up period. C-Comparison: Comparison group A comparison was made among one receiving a placebo, another serving as a control group in which food was substituted with food that does not contain " Bifidobacterium longum BB536 (B.longum), Bifidobacterium breve B-3 (B.breve) ", and group with no intervention. O-Outcome: Evaluation items Main outcomes: Abdominal fat Secondary outcomes: Body composition S-Study design: Research design The research designs used in the literature were randomized parallel group controlled trials (RCTPs), randomized crossover trials (RCTCOs), and quasi-randomized controlled trials (quasi-RCTs). In addition, the languages of presentation were documents written in Japanese and English. As a general rule, the presentation format will be an original paper, and papers in the form of short reports or summaries will also be accepted if the content can be specified. Abstracts of academic conference presentations (conference minutes) were excluded because their descriptive content was considered insufficient. There was no question as to whether or not the journal in which the article was published had been peer-reviewed. To avoid publication bias, we also included studies with results published in clinical trial registry databases. Regarding gray literature, we decided to use doctoral theses, reports from government agencies, think tanks, etc. whose detailed contents could be identified.

Exclusion criteria

Exclusion criteria: The literature which does not meet the key inclusion criteria will be excluded.

Design outcomes

Primary

MeasureTime frame
Abdominal fat

Secondary

MeasureTime frame
Body composition

Countries

Japan

Contacts

Public ContactMasakazu Katsu

FANCL Corporation Functional Food Research Institute

gakujutsu_sdi@fancl.co.jp045-226-1392

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026